What’s the problem? Viruses are essential tools in modern biotechnology, with applications in cancer immunotherapy, gene therapy, and vaccine development. However, producing viruses efficiently at clinical and commercial scale remains a major bottleneck. Many
The MIEHT program offers structured training in need identification, customer discovery, problem triaging, and iterative solution development. Through seminars, hands-on exploration, and mentorship, students gain practical experience in evaluating clinical challenges and advancing innovative concepts that can improve patient care and healthcare system efficiency.
From February 8 to 11, the BioVentures team attended the 2026 AUTM Annual Meeting in Seattle to connect with peers, explore opportunities, and strengthen partnerships.
BioVentures has been selected as one of the awardees of the 2025 Growth Accelerator Fund Competition (GAFC), a program of the U.S. Small Business Administration (SBA) designed to support the
BioVentures launched the first CADET cohort, supporting cancer researchers with training, mentorship, and tools to translate discoveries into real-world impact.
BioVentures participated in the AUTM University Conference 2025, held from October 26–29 in New Orleans. The event brought together professionals from technology transfer offices across the country to exchange knowledge,
BioVentures attended Bio on the Bayou 2025 in New Orleans, a leading regional event that brought together innovators, researchers, and investors to showcase the latest advances in biotechnology, medtech, and
BioVentures LLC has been awarded a $15,000 Chancellor’s Circle Grant to support the initiative “Empowering Student Innovation: Building an Innovation and Entrepreneurship Ecosystem at UAMS.” The program provides UAMS medical and STEM students
The latest UAMS Showcase of Medical Discoveries, held on October 22 at the Jackson T. Stephens Spine & Neurosciences Institute, celebrated the spirit of innovation and entrepreneurship driving research at UAMS. The event
The NIH-funded CADET program, administered by BioVentures, will provide cancer researchers with the entrepreneurial training and mentorship needed to bring lab discoveries to patients. Applications are open until October 31.
Newly granted patent: U.S. Patent No. 12,370,338 B2, “Immersive Distraction Therapy.
Join us on October 22, from 4–6 PM at the Jack Stephens Spine Institute (12th Floor) for the next UAMS Showcase of Medical Discoveries, focused on UAMS intellectual property and
DISCLAIMER: Information on this website is not legal advice and should not be relied on as such. The law can change and the information contained on this site may be outdated, so you should always consult an attorney regarding your specific issues in view of the current state of the law. Please contact our team at bioventures@uams.edu if you have any questions and we can help determine a course of action.
